Diabetes Pipeline Landscape Research Report 2024: Comprehensive Insights About 200+ Companies and 200+ Pipeline Drugs
November 21, 2024 04:09 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Diabetes - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Diabetes - Pipeline Insight, 2024" report...
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity Market Analysis 2024 - The Use of GLP-1R Agonists is Expected to Quadruple in the Next 10 Years, at a CAGR of 14.9%
June 04, 2024 04:17 ET
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis" report has been...
Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2032
April 25, 2024 10:39 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's...
Global Prediabetes Treatment Market Analysis & Forecast Report 2024-2034
April 23, 2024 04:01 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Prediabetes Treatment Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
Global Prediabetes Market Analysis Report 2024-2030, Featuring Valbiotis, RESVERLOGIX, Caelus Health, SciMar, Boston Therapeutics, Aphaia Pharma, AstraZeneca and Bristol-Myers Squibb
April 15, 2024 11:18 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Global Prediabetes Market Size, Share & Trends Analysis Report by Drug Class (Diguanide, Thiazolidinediones), Age Group (Children, Adult), Region,...
Glucagon-like Peptide-1 (GLP-1) Agonists for 7MM: Market Size, Target Population, Competitive Landscape & Forecasts, 2020-2023 and 2024-2034
March 04, 2024 11:24 ET
|
Research and Markets
Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ...
Global Glucagon-Like Peptide 1 (GLP-1) Agonist (Tirzepatide, Semaglutide, Dulaglutide, Others) Market Research Report 2024
February 26, 2024 11:24 ET
|
Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Global Glucagon-Like Peptide 1 (GLP-1) Agonist market (2024 Edition): Analysis by Type, End-Use (Type 2 Diabetes, NASH, Obesity), By Distribution...
Global Incretin Based Drugs Market Report 2023-2029 with Analysis of Leading Market Players like Eli Lilly and Co, Boehringer Ingelheim, Novo Nordisk, and AstraZeneca Among Others
February 20, 2024 09:16 ET
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4...
China Diabetes Care Drugs Market to Reach USD 13.73 Billion by 2028, Propelled by Rising Prevalence and Advanced Treatment Options
January 30, 2024 19:57 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "China Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...
Global Glucagon-like Peptide 1 (GLP-1) Market Soars to $18.75 Billion by 2023, Fueled by Increasing Healthcare Expenditure and Aging Population
November 10, 2023 08:48 ET
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Glucagon-like Peptide 1 (GLP-1) Market (by Product, Route of Administration, & Region): Insights and Forecast with Potential Impact of...